Literature DB >> 15925433

Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation.

Jianjun Chen1, Fang Fang, Xiangzhong Li, Haiyan Chang, Ze Chen.   

Abstract

The ability of a single dose of plasmid DNA encoding neuraminidase (NA) or hemagglutinin (HA) from influenza virus A/PR/8/34 (PR8) (H1N1) to protect against homologous virus infection was examined in BALB/c mice. In the present study, mice were immunized once with 30 microg of NA or HA DNA by electroporation. Four weeks or 28 weeks after immunization, mice were challenged with a lethal dose of homologous virus and the ability of NA or HA DNA to protect the mice from influenza was evaluated. We found that a single inoculation of NA DNA could provide protection against influenza virus challenge as well as long-term protection against viral infection. Whereas, the mice immunized with a single dose of HA DNA could not be protected. In addition, neonatal mice immunized with a single dose of 30 microg of NA DNA could be provided with significant protection against viral infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925433     DOI: 10.1016/j.vaccine.2005.03.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  Electroporation-mediated gene delivery.

Authors:  Jennifer L Young; David A Dean
Journal:  Adv Genet       Date:  2014-12-11       Impact factor: 1.944

2.  Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus.

Authors:  Ke Xu; Zhi-Yang Ling; Liang Sun; Ying Xu; Chao Bian; Yuan He; Wei Lu; Ze Chen; Bing Sun
Journal:  Viral Immunol       Date:  2011-02       Impact factor: 2.257

3.  The migration of T cells in response to influenza virus is altered in neonatal mice.

Authors:  J Louise Lines; Samantha Hoskins; Melissa Hollifield; Linda S Cauley; Beth A Garvy
Journal:  J Immunol       Date:  2010-07-23       Impact factor: 5.422

4.  Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.

Authors:  Fu-Shi Quan; Min-Chul Kim; Byeong-Jae Lee; Jae-Min Song; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2012-06-02       Impact factor: 3.616

Review 5.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

6.  An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Authors:  Syed Muaz Khalil; Daniel R Tonkin; Andrew T Snead; Griffith D Parks; Robert E Johnston; Laura J White
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus.

Authors:  Quanjiao Chen; Haimen Kuang; Huadong Wang; Fang Fang; Zhongdong Yang; Zhiping Zhang; Xianen Zhang; Ze Chen
Journal:  Virus Genes       Date:  2008-12-10       Impact factor: 2.332

8.  Renalase's expression and distribution in renal tissue and cells.

Authors:  Feng Wang; Tao Xing; Junhui Li; Mei Bai; Ruimin Hu; Zhonghua Zhao; Shoufu Tian; Zhigang Zhang; Niansong Wang
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

9.  Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

Authors:  Sang-Moo Kang; Dae-Goon Yoo; Aleksandr S Lipatov; Jae-Min Song; C Todd Davis; Fu-Shi Quan; Li-Mei Chen; Ruben O Donis; Richard W Compans
Journal:  PLoS One       Date:  2009-03-02       Impact factor: 3.240

10.  Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.

Authors:  Jian Luo; Dan Zheng; Wenjie Zhang; Fang Fang; Hanzhong Wang; Ying Sun; Yahong Ding; Chengfei Xu; Quanjiao Chen; Hongbo Zhang; Ding Huang; Bing Sun; Ze Chen
Journal:  Virol J       Date:  2012-11-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.